Petra Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors (NCT04073680) | Petra Pharma | 2020-09-01 |
Track Petra Pharma automatically
Every clearance here is in the API, with alerts when new ones post.